NEW YORK (GenomeWeb News) – Privately held firms Gentag and MacroArray Technologies said today that they will collaborate on developing a wireless immunoassay for prostate cancer.
The new test would combine Gentag’s cell-phone sensor technology with MacroArray’s proteomics discovery technology to create a disposable, wireless diagnostic test.
Gentag said the test would work similarly to currently available pregnancy strip tests, with men placing a urine sample on a test strip that incorporates an imbedded wireless tag. Antibodies on the strip would react with the sample and resulting data would be sent to an attending physician.
The firms plan to develop additional diagnostic tests based on their combined technologies, but the prostate cancer test is first in the pipeline.